Related references
Note: Only part of the references are listed.The natural history of epithelioid sarcoma. A retrospective multicentre case-series within the Italian Sarcoma Group
Anna Maria Frezza et al.
EJSO (2020)
Primary Epithelioid Sarcoma of the Zygomatic Bone
Henry Tran et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2019)
Epithelioid hemangioendothelioma of the bone A case report with findings of bone scintigraphy
Yijin Xu et al.
MEDICINE (2019)
Pseudomyogenic Hemangioendothelioma
Ayah Al-Qaderi et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2019)
Epithelioid Hemangioendothelioma: Update on Diagnosis and Treatment
Ari Rosenberg et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2018)
Oncogenic roles of SMARCB1/INI1 and its deficient tumors
Kenichi Kohashi et al.
CANCER SCIENCE (2017)
Epithelioid Sarcoma: Diagnostic Features and Genetics
Khin Thway et al.
ADVANCES IN ANATOMIC PATHOLOGY (2016)
Nuclear Brachyury Expression Is Consistent in Chordoma, Common in Germ Cell Tumors and Small Cell Carcinomas, and Rare in Other Carcinomas and Sarcomas An Immunohistochemical Study of 5229 Cases
Markku Miettinen et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Epithelioid sarcoma: opportunities for biology-driven targeted therapy
Jonathan Noujaim et al.
FRONTIERS IN ONCOLOGY (2015)
Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material
Francois Le loarer et al.
GENES CHROMOSOMES & CANCER (2014)
SMARCB1 protein and mRNA loss is not caused by promoter and histone hypermethylation in epithelioid sarcoma
Gergo Papp et al.
MODERN PATHOLOGY (2013)
Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions
Lisa M. Sullivan et al.
MODERN PATHOLOGY (2013)
Hemangioendothelioma
Luis Requena et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2013)
Assessment of integrase interactor 1 (INI-1) expression in primary tumours of bone
Roberto Tirabosco et al.
HISTOPATHOLOGY (2012)
INI1-Deficient Tumors: Diagnostic Features and Molecular Genetics
Travis J. Hollmann et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Prognostic determinants in epithelioid sarcoma
Patrizia Gasparini et al.
EUROPEAN JOURNAL OF CANCER (2011)
Epithelioid Sarcoma and Unclassified Sarcoma with Epithelioid Features: Clinicopathological Variables, Molecular Markers, and a New Experimental Model
Aniket Sakharpe et al.
ONCOLOGIST (2011)
Primary Epithelioid Sarcoma of Bone Report of a Unique Case, With Immunohistochemical and Fluorescent In Situ Hybridization Confirmation of INI1 Deletion
Delphine Raoux et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
The role of SMARCB1/INI1 in development of rhabdoid tumor
Charles W. M. Roberts et al.
CANCER BIOLOGY & THERAPY (2009)
Genomic Analysis Using High-Density Single Nucleotide Polymorphism-Based Oligonucleotide Arrays and Multiplex Ligation-Dependent Probe Amplification Provides a Comprehensive Analysis of INI1/SMARCB1 in Malignant Rhabdoid Tumors
Eric M. Jackson et al.
CLINICAL CANCER RESEARCH (2009)
Prognostic Factors for Survival in Patients with Epithelioid Sarcoma: 441 Cases from the SEER Database
Muhammad Umar Jawad et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2009)
Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor
Kenichi Kohashi et al.
HUMAN PATHOLOGY (2009)
Epithelioid sarcoma in children and adolescents - A report from the Italian Soft Tissue Sarcoma Committee
M Casanova et al.
CANCER (2006)
SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas
P Modena et al.
CANCER RESEARCH (2005)
Patterns of keratin polypeptides in 110 biphasic, monophasic, and poorly differentiated synovial sarcomas
M Miettinen et al.
VIRCHOWS ARCHIV (2000)
Share Paper
